Anpac Bio Medical Stock Current Valuation
| ANPCDelisted Stock | USD 4.37 0.20 4.38% |
Valuation analysis of Anpac Bio Medical helps investors to measure Anpac Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Anpac Bio's price fluctuation is very steady at this time. Calculation of the real value of Anpac Bio Medical is based on 3 months time horizon. Increasing Anpac Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Anpac Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Anpac Stock. However, Anpac Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.37 | Real 4.15 | Hype 4.37 | Naive 3.37 |
The real value of Anpac Stock, also known as its intrinsic value, is the underlying worth of Anpac Bio Medical Company, which is reflected in its stock price. It is based on Anpac Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Anpac Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Anpac Bio Medical helps investors to forecast how Anpac stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Anpac Bio more accurately as focusing exclusively on Anpac Bio's fundamentals will not take into account other important factors: Anpac Bio Medical Company Current Valuation Analysis
Anpac Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Anpac Bio Current Valuation | 9.28 M |
Most of Anpac Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Anpac Bio Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Anpac Bio Medical has a Current Valuation of 9.28 M. This is 99.94% lower than that of the Healthcare sector and 99.8% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
Anpac Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anpac Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics of similar companies.Anpac Bio is currently under evaluation in current valuation category among its peers.
Anpac Fundamentals
| Return On Equity | -2.43 | |||
| Return On Asset | -0.53 | |||
| Operating Margin | (8.71) % | |||
| Current Valuation | 9.28 M | |||
| Shares Outstanding | 6.27 M | |||
| Shares Owned By Insiders | 2.15 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Number Of Shares Shorted | 44.48 K | |||
| Price To Book | 5.67 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 12.04 M | |||
| Gross Profit | 12.25 M | |||
| EBITDA | (78.4 M) | |||
| Net Income | (103.6 M) | |||
| Cash And Equivalents | 462 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 19.81 M | |||
| Debt To Equity | 1.44 % | |||
| Current Ratio | 0.39 X | |||
| Book Value Per Share | 10.63 X | |||
| Cash Flow From Operations | (55.06 M) | |||
| Short Ratio | 2.50 X | |||
| Earnings Per Share | (11.45) X | |||
| Target Price | 8.0 | |||
| Beta | 1.56 | |||
| Market Capitalization | 27.41 M | |||
| Total Asset | 40.47 M | |||
| Retained Earnings | (577.54 M) | |||
| Working Capital | (28.58 M) | |||
| Current Asset | 23.44 M | |||
| Current Liabilities | 68.22 M | |||
| Z Score | -26.09 | |||
| Net Asset | 40.47 M |
About Anpac Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anpac Bio Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |